Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Sales (2017 - 2025)

Puma Biotechnology's Return on Sales history spans 9 years, with the latest figure at 0.23% for Q4 2025.

  • For Q4 2025, Return on Sales fell 45.0% year-over-year to 0.23%; the TTM value through Sep 2025 reached 0.14%, up 5.0%, while the annual FY2024 figure was 0.1%, 1.0% up from the prior year.
  • Return on Sales reached 0.23% in Q4 2025 per PBYI's latest filing, down from 0.16% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.25% in Q3 2024 to a low of 0.97% in Q3 2021.
  • Average Return on Sales over 5 years is 0.0%, with a median of 0.05% recorded in 2023.
  • Peak YoY movement for Return on Sales: surged 96bps in 2022, then tumbled -45bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.08% in 2021, then plummeted by -184bps to 0.06% in 2022, then soared by 366bps to 0.17% in 2023, then grew by 29bps to 0.22% in 2024, then tumbled by -207bps to 0.23% in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Return on Sales are 0.23% (Q4 2025), 0.16% (Q3 2025), and 0.11% (Q2 2025).